• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎的免疫调节与免疫治疗。

Immunomodulation and immunotherapeutics of COVID-19.

机构信息

Department of Biochemistry, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, Punjab, India.

Department of Chemistry, School of Chemical Engineering and Physical Science, Lovely Professional University, Phagwara, Punjab, India.

出版信息

Clin Immunol. 2021 Oct;231:108842. doi: 10.1016/j.clim.2021.108842. Epub 2021 Aug 27.

DOI:10.1016/j.clim.2021.108842
PMID:34461289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8393504/
Abstract

Severe acute respiratory syndrome coronavirus-2 causes coronavirus disease 2019, a pandemic which was originated from Wuhan city of China. The pandemic has affected millions of people worldwide. The pathogenesis of SARS-CoV-2 is characterized by a cytokine storm in the blood (cytokinemia) and tissues, especially the lungs. One of the major repercussions of this inflammatory process is the endothelial injury-causing intestinal bleeding, coagulopathy, and thromboembolism which result in various sudden and unexpected post-COVID complications including kidney failure, myocardial infarction, or multiorgan failure. In this review, we have summarized the immune responses, biochemical changes, and inflammatory responses in the human body after infection with the SARS-CoV-2 virus. The increased amount of inflammatory cytokines, chemokines, and involvement of complement proteins in inflammatory reaction increase the risk of occurrence of disease.

摘要

严重急性呼吸综合征冠状病毒 2 引起 2019 年冠状病毒病,这是一种起源于中国武汉市的大流行疾病。该大流行疾病已影响了全球数百万人。SARS-CoV-2 的发病机制以血液(细胞因子血症)和组织中的细胞因子风暴为特征,特别是肺部。该炎症过程的主要后果之一是内皮损伤导致肠道出血、凝血功能障碍和血栓栓塞,从而导致各种突发和意外的新冠病毒感染后并发症,包括肾衰竭、心肌梗死或多器官衰竭。在这篇综述中,我们总结了人体感染 SARS-CoV-2 病毒后的免疫反应、生化变化和炎症反应。炎症反应中炎症细胞因子、趋化因子的增加量和补体蛋白的参与增加了疾病发生的风险。

相似文献

1
Immunomodulation and immunotherapeutics of COVID-19.新型冠状病毒肺炎的免疫调节与免疫治疗。
Clin Immunol. 2021 Oct;231:108842. doi: 10.1016/j.clim.2021.108842. Epub 2021 Aug 27.
2
COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.COVID-19 免疫病理学,重点关注 Th17 反应和基于细胞的免疫调节治疗:潜在靶点和挑战。
Scand J Immunol. 2022 Feb;95(2):e13131. doi: 10.1111/sji.13131. Epub 2022 Jan 3.
3
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.免疫调节治疗严重 COVID-19 肺炎:现状。
Front Immunol. 2020 Nov 9;11:577442. doi: 10.3389/fimmu.2020.577442. eCollection 2020.
4
COVID-19 and Sepsis.新型冠状病毒肺炎与脓毒症。
Turk J Med Sci. 2021 Dec 17;51(SI-1):3301-3311. doi: 10.3906/sag-2108-239.
5
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.间充质干细胞免疫调节:探索控制 COVID-19 相关细胞因子风暴的方法。
Stem Cells. 2021 Jun;39(6):707-722. doi: 10.1002/stem.3354. Epub 2021 Mar 7.
6
Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.对 COVID-19 病理生理学、免疫发病机制、检测和治疗的分子洞察。
DNA Cell Biol. 2021 Jul;40(7):858-868. doi: 10.1089/dna.2021.0068. Epub 2021 May 14.
7
Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.牙髓干细胞的免疫调节和再生特性:一种治疗 2019 年冠状病毒病的潜在疗法。
Cell Transplant. 2020 Jan-Dec;29:963689720952089. doi: 10.1177/0963689720952089.
8
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.辅助免疫疗法治疗重症 COVID-19 患者。
Cell Rep Med. 2020 May 19;1(2):100016. doi: 10.1016/j.xcrm.2020.100016. Epub 2020 Apr 30.
9
COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.COVID-19 及其治疗方法:特别强调基于间充质干细胞的治疗。
Stem Cell Rev Rep. 2021 Feb;17(1):113-131. doi: 10.1007/s12015-020-10037-2.
10
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.探索间充质干细胞在治疗严重冠状病毒病 19 方面的免疫调节作用。
Cells. 2022 Jul 12;11(14):2175. doi: 10.3390/cells11142175.

引用本文的文献

1
Hematological Markers in Thromboembolic Events: A Comparative Study of COVID-19 and Non-COVID-19 Hospitalized Patients.血栓栓塞事件中的血液学标志物:COVID-19与非COVID-19住院患者的比较研究
J Clin Med. 2025 May 5;14(9):3192. doi: 10.3390/jcm14093192.
2
The COVID-19 Pandemic Heightens Interest in Cytokine Storm Disease and Advances in Machine Learning Diagnosis, Telemedicine, and Primordial Prevention of Rheumatic Diseases.新冠疫情提高了对细胞因子风暴疾病的关注度,并推动了机器学习诊断、远程医疗以及风湿病初级预防等方面的进展。
Eur J Rheumatol. 2024 Nov 28;11(4):410-417. doi: 10.5152/eurjrheum.2024.23059.
3
Association of Immune Semaphorins with COVID-19 Severity and Outcomes.

本文引用的文献

1
COVID-19: insights into virus-receptor interactions.新型冠状病毒肺炎:病毒-受体相互作用的见解
Mol Biomed. 2021;2(1):10. doi: 10.1186/s43556-021-00033-4. Epub 2021 Apr 10.
2
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
3
In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection.
免疫信号素与新冠病毒疾病严重程度及预后的关联
Biomedicines. 2023 Oct 13;11(10):2786. doi: 10.3390/biomedicines11102786.
4
Characterizing distinct profiles of immune and inflammatory response with age to Omicron infection.描述奥密克戎感染后免疫和炎症反应随年龄变化的不同特征。
Front Immunol. 2023 Jun 30;14:1189482. doi: 10.3389/fimmu.2023.1189482. eCollection 2023.
5
Mouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression.新冠病毒感染的小鼠模型再现的是炎症途径,而不是基因表达。
PLoS Pathog. 2022 Sep 26;18(9):e1010867. doi: 10.1371/journal.ppat.1010867. eCollection 2022 Sep.
中东呼吸综合征冠状病毒(MERS-CoV)感染期间细胞因子表达谱的体内和体外评估
J Inflamm Res. 2021 May 21;14:2121-2131. doi: 10.2147/JIR.S312337. eCollection 2021.
4
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11.人类单克隆抗体 47D11 对 SARS-CoV 和 SARS-CoV-2 的交叉中和作用的结构见解。
Sci Adv. 2021 Jun 2;7(23). doi: 10.1126/sciadv.abf5632. Print 2021 Jun.
5
Type I and III interferon responses in SARS-CoV-2 infection.SARS-CoV-2 感染中的 I 型和 III 型干扰素反应。
Exp Mol Med. 2021 May;53(5):750-760. doi: 10.1038/s12276-021-00592-0. Epub 2021 May 6.
6
Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.肥胖作为 COVID-19 重症和并发症的风险因素:综述。
Cells. 2021 Apr 17;10(4):933. doi: 10.3390/cells10040933.
7
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.SARS-CoV-2 的结构蛋白和非结构蛋白及其在 COVID-19 中的治疗靶点的作用。
Cells. 2021 Apr 6;10(4):821. doi: 10.3390/cells10040821.
8
Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity.患有主要非传染性疾病(慢性冠状动脉综合征、糖尿病和肥胖症)患者的全身炎症与新冠病毒疾病死亡率
J Clin Med. 2021 Apr 7;10(8):1545. doi: 10.3390/jcm10081545.
9
Pharmacological management of COVID-19 in type 2 diabetes.2 型糖尿病合并 COVID-19 的药物治疗管理。
J Diabetes Complications. 2021 Jul;35(7):107927. doi: 10.1016/j.jdiacomp.2021.107927. Epub 2021 Apr 17.
10
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.减轻新型冠状病毒肺炎(SARS-CoV-2)感染诱导的细胞因子风暴的影响及其意义
J Inflamm Res. 2021 Apr 16;14:1487-1510. doi: 10.2147/JIR.S301784. eCollection 2021.